Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens

Leukemia and Lymphoma

Volumn 42, Issue 1-2, 2001, Pages 145-150

  Ruiz Arguelles G J ^a   Ruiz Arguelles A ^a   Gomez Almaguer D ^a   Lopez Martinez B ^a   Abreu Diaz G ^a   Bravo, G ^a   Jaime Perez J ^a  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

Author keywords

Allogeneic; BMT; Engraftment; Minitransplant; Stem cell

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; GRAFT FAILURE; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; LEUKOCYTE COUNT; MONONUCLEAR CELL; MYELODYSPLASIA; NEUTROPHIL; PRIORITY JOURNAL; THALASSEMIA MAJOR; TIME;

EID: 0034926219     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097686     Document Type: Article

References (19)

1. Bone marrow transplantation in malignant disease
2. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeoablative therapy
3. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematological diseases
4. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias
5. Outpatient allografting with minimally myelosuppressive, immunosuppressive conditioning of low-dose TBI and post-grafting cyclosporine and mycophenolate mofetil
6. Nonmyeloablative transplants: Preclinical and clinical results
7. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis
8. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen are less costly and can be safely performed on an outpatient basis
9. Defining a therapeutic dose of peripheral blood stem cells
10. Collection and processing of peripheral blood hematopoietic progenitor cells
11. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood cell transplantation: Effect of graft size
12. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy
13. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis
14. Flow cytometry in the clinical laboratory. Principles, applications and problems
15. Caracterización y evaluación de céluias totipotenciales en sangre periférica y médula ósea
16. Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization
17. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation
18. Expression of cell surface markers during differentiation of CD34+, CD38 -/lo fetal and adult bone marrow cells
19. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 22 patients